These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 3552534
21. [Study of simultaneous dosage of carcino-embryonic antigen (C.E.A.) and beta 2-microglobulin in serum and pleural liquid (author's transl)]. Poirier R, Bisset JP, Roux F, Salasc de Surmont B, Kleisbauer JP, Laval P. Rev Fr Mal Respir; 1979; 7(1):29-33. PubMed ID: 91184 [Abstract] [Full Text] [Related]
22. [Clinical evaluation of serum beta 2-microglobulin in squamous cell carcinoma of the lung]. Higuchi Y, Togawa T, Moriya H, Hoshi K, Satoh T, Kimura K. Gan No Rinsho; 1986 Dec; 32(15):1919-24. PubMed ID: 3543434 [Abstract] [Full Text] [Related]
23. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P. J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [Abstract] [Full Text] [Related]
24. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors]. Suzuki Y, Ishii R, Otsuka R, Ogawa Y, Kikuoka M, Hirano K, Tanaka R. No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088 [Abstract] [Full Text] [Related]
25. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J. Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125 [Abstract] [Full Text] [Related]
26. Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress. DiSaia PJ, Morrow CP, Haverback BJ, Dyce BJ. Obstet Gynecol; 1976 Jan 15; 47(1):95-9. PubMed ID: 1246404 [Abstract] [Full Text] [Related]
27. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Nonaka M, Kataoka D, Yamamoto S, Bito A, Matsuoka J, Kawada T, Takaba T. Ann Thorac Cardiovasc Surg; 2004 Oct 15; 10(5):281-4. PubMed ID: 15563262 [Abstract] [Full Text] [Related]
28. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M, Itoh T. Eur J Cardiothorac Surg; 2004 Apr 15; 25(4):520-2. PubMed ID: 15037265 [Abstract] [Full Text] [Related]
29. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]. Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, Larbre H. Rev Mal Respir; 1994 Apr 15; 11(4):379-84. PubMed ID: 7973038 [Abstract] [Full Text] [Related]
30. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment. Waalkes TP, Abeloff MD, Woo KB, Ettinger DS, Ruddon RW, Aldenderfer P. Cancer Res; 1980 Dec 15; 40(12):4420-7. PubMed ID: 6254646 [Abstract] [Full Text] [Related]
31. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension. Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N. Cancer; 2003 Aug 01; 98(3):535-41. PubMed ID: 12879471 [Abstract] [Full Text] [Related]
32. Carcinoembryonic antigen in bronchogenic carcinoma. Zatloukal P, Voslárová Z, Mĕricka O, Svarcová H, Schützner J. Neoplasma; 1987 Aug 01; 34(1):73-6. PubMed ID: 3561607 [Abstract] [Full Text] [Related]
33. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients. Ogushi F, Fukuoka M, Takada M, Tamai S, Sakai N, Negoro S, Okunaka N, Sone S, Tsubura E. Jpn J Clin Oncol; 1984 Sep 01; 14(3):321-7. PubMed ID: 6090732 [Abstract] [Full Text] [Related]
34. [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions]. Jiang XF, Zhu YJ, Zhao WL, Ma X, Lo WC. Zhonghua Zhong Liu Za Zhi; 1986 Nov 01; 8(6):430-1. PubMed ID: 3582109 [Abstract] [Full Text] [Related]
35. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy]. Tatsuno I, Konishi K. Rinsho Hoshasen; 1983 Nov 01; 28(12):1487-90. PubMed ID: 6323796 [No Abstract] [Full Text] [Related]
36. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Lunde OC, Havig O. Acta Chir Scand; 1982 Nov 01; 148(2):189-93. PubMed ID: 7148317 [Abstract] [Full Text] [Related]
37. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy]. Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Takahashi K, Sasaki Y, Ohkura H. Gan To Kagaku Ryoho; 1984 May 01; 11(5):1056-63. PubMed ID: 6202246 [Abstract] [Full Text] [Related]
38. Tissue polypeptide antigen in bronchogenic carcinoma. Zatloukal P, Glagolicová A, Linhart M, Sebes A, Hencl P, Mĕricka O. Neoplasma; 1993 May 01; 40(5):301-3. PubMed ID: 8272159 [Abstract] [Full Text] [Related]
39. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma. Kohno N, Hirasawa Y, Kondo K, Fujioka S, Fujino S, Abe M, Yokoyama A, Hiwada K, Watanabe K, Nishimura J. Cancer Detect Prev; 1997 May 01; 21(2):124-8. PubMed ID: 9101072 [Abstract] [Full Text] [Related]
40. [Analysis of pathological state of benign monoclonal gammopathy by beta 2-microglobulin and CEA]. Michibayashi T, Izawa A, Asano M. Rinsho Byori; 1989 Sep 01; 37(9):1033-7. PubMed ID: 2691739 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]